Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Kiyoko Nojima
Observed name:
K. Nojima
Institution:
National Institute of Infectious Diseases
Observed institution:
National Institute of Infectious Diseases
OpenAlex ID:
A5043512697
Temporal maturation of neutralizing antibodies in COVID-19 convalescent individuals improves potency and breadth to circulating SARS-CoV-2 variants
2021
·
Saya Moriyama
, Yu Adachi
, et al.
·
Immunity
·
137
Vaccination-infection interval determines cross-neutralization potency to SARS-CoV-2 Omicron after breakthrough infection by other variants
2022
·
Sho Miyamoto
, Takeshi Arashiro
, et al.
·
Med
·
78
PDF
Safety and immunogenicity of the Pfizer/BioNTech SARS-CoV-2 mRNA third booster vaccine dose against the BA.1 and BA.2 Omicron variants
2022
·
Yohei Seki
, Yasuo Yoshihara
, et al.
·
Med
·
32
PDF
Aggregation analysis of pharmaceutical human immunoglobulin preparations using size-exclusion chromatography and analytical ultracentrifugation sedimentation velocity
2012
·
Elena Krayukhina
, Susumu Uchiyama
, et al.
·
Journal of Bioscience and Bioengineering
·
30
Inactivation of hepatitis A virus by heat and high hydrostatic pressure: variation among laboratory strains
2008
·
N. Shimasaki
, T. Kiyohara
, et al.
·
Vox Sanguinis
·
25
Saturation time of exposure interval for cross-neutralization response to SARS-CoV-2: Implications for vaccine dose interval
2023
·
Sho Miyamoto
, Yudai Kuroda
, et al.
·
iScience
·
8
Development of a novel dengue virus serotype‐specific multiplex real‐time reverse transcription–polymerase chain reaction assay for blood screening
2016
·
Kenta Tezuka
, Madoka Kuramitsu
, et al.
·
Transfusion
·
6
Single amino acid substitution in the hepatitis B virus surface antigen (HBsAg) “a” determinant affects the detection sensitivity of an HBsAg diagnostic kit
2010
·
Toshiaki Mizuochi
, Saeko Mizusawa
, et al.
·
Clinica Chimica Acta
·
4
Specific COVID-19 risk behaviors and the preventive effect of personal protective equipment among healthcare workers in Japan
2023
·
Reiko Shimbashi
, Teiichiro Shiino
, et al.
·
Global Health & Medicine
·
3
PDF
The 2nd Meeting of National Control Laboratories for Vaccines and Biologicals in the Western Pacific
2018
·
Hokyung Oh
, Jinho Shin
, et al.
·
Osong Public Health and Research Perspectives
·
2
Development of a novel safety assessment method for quality control of mRNA vaccines based on lung biomarker gene expression
2025
·
Kou Hiraga
, Haruka Momose
, et al.
·
Vaccine
·
1
Establishment of a reference material for standardization of the anti-complementary activity test in intravenous immunoglobulin products used in Japan: A collaborative study
2017
·
Kiyoko Nojima
, Kazu Okuma
, et al.
·
Biologicals
·
1
Reduced Resistance of SARS-CoV-2 Variants Toward Affinity-Matured Serological Immunity
2021
·
Saya Moriayma
, Yu Adachi
, et al.
·
SSRN Electronic Journal
Show more works
View as search
Works count:
13
Citation count:
327
H-index:
6
I10-index:
5
Year
Topic
Type